M Furihata

1.3k total citations
39 papers, 1.0k citations indexed

About

M Furihata is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, M Furihata has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in M Furihata's work include Cancer-related Molecular Pathways (15 papers), Cancer Research and Treatments (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). M Furihata is often cited by papers focused on Cancer-related Molecular Pathways (15 papers), Cancer Research and Treatments (6 papers) and Bladder and Urothelial Cancer Treatments (5 papers). M Furihata collaborates with scholars based in Japan, China and United States. M Furihata's co-authors include Y Ohtsuki, H Sonobe, Shohei Ogoshi, Hiroshi Murakami, J. Iwata, Taro Shuin, Tamotsu Takeuchi, Yuji Ohtsuki, A. Inoue and Nobukazu Hayashi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Oncogene and British Journal of Cancer.

In The Last Decade

M Furihata

38 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Furihata Japan 19 526 401 326 161 130 39 1.0k
Brian Cao United States 17 638 1.2× 381 1.0× 230 0.7× 174 1.1× 131 1.0× 37 1.2k
Barbara Loftus Ireland 17 608 1.2× 527 1.3× 269 0.8× 244 1.5× 219 1.7× 30 1.2k
Shi‐Xue Hu United States 12 397 0.8× 574 1.4× 178 0.5× 94 0.6× 201 1.5× 17 956
Frank B. Fromowitz United States 18 488 0.9× 340 0.8× 436 1.3× 175 1.1× 200 1.5× 40 1.2k
Antonella De Stefani Italy 18 315 0.6× 436 1.1× 223 0.7× 98 0.6× 250 1.9× 37 1.2k
J W Shay Japan 9 577 1.1× 454 1.1× 146 0.4× 123 0.8× 145 1.1× 10 1.3k
Jeannine Lacroix Germany 15 253 0.5× 490 1.2× 143 0.4× 186 1.2× 118 0.9× 25 826
C. Fisher United Kingdom 12 351 0.7× 687 1.7× 221 0.7× 279 1.7× 158 1.2× 16 1.1k
Andre L. Reed United States 8 613 1.2× 505 1.3× 114 0.3× 186 1.2× 178 1.4× 11 1.0k
Concetta Chiarelli Italy 11 246 0.5× 308 0.8× 272 0.8× 79 0.5× 139 1.1× 16 839

Countries citing papers authored by M Furihata

Since Specialization
Citations

This map shows the geographic impact of M Furihata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Furihata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Furihata more than expected).

Fields of papers citing papers by M Furihata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Furihata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Furihata. The network helps show where M Furihata may publish in the future.

Co-authorship network of co-authors of M Furihata

This figure shows the co-authorship network connecting the top 25 collaborators of M Furihata. A scholar is included among the top collaborators of M Furihata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Furihata. M Furihata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikezoe, Takayuki, Jing Yang, Chie Nishioka, et al.. (2016). The fifth epidermal growth factor-like region of thrombomodulin exerts cytoprotective function and prevents SOS in a murine model. Bone Marrow Transplantation. 52(1). 73–79. 29 indexed citations
2.
Kakinuma, Yoshihiko, Atsushi Kurabayashi, Mikiya Fujieda, et al.. (2011). Conditional VHL gene deletion activates a local NO-VEGF axis in a balanced manner reinforcing resistance to endothelium-targeted glomerulonephropathy. Nephrology Dialysis Transplantation. 26(12). 4023–4031. 8 indexed citations
3.
Baba, Masaya, M Furihata, Seung‐Beom Hong, et al.. (2008). Kidney-Targeted Birt-Hogg-Dube Gene Inactivation in a Mouse Model: Erk1/2 and Akt-mTOR Activation, Cell Hyperproliferation, and Polycystic Kidneys. JNCI Journal of the National Cancer Institute. 100(2). 140–154. 182 indexed citations
4.
Takeuchi, Tamotsu, Yoshihiro Adachi, H Sonobe, M Furihata, & Y Ohtsuki. (2006). A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion. Oncogene. 25(53). 7059–7069. 31 indexed citations
5.
Okuda, Heiwa, M Toyota, Waka Ishida, et al.. (2005). Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma. Oncogene. 25(12). 1733–1742. 71 indexed citations
6.
Hayashi, Hideki, et al.. (2001). Immunohistochemical findings of nitric oxide synthase expression in urothelial transitional cell carcinoma including dysplasia. Oncology Reports. 8(6). 1275–9. 9 indexed citations
7.
Liang, Sheng‐Ben, et al.. (2000). Overexpression of cyclin D1 in nonmelanocytic skin cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 436(4). 370–376. 31 indexed citations
8.
Sonobe, H, Tamotsu Takeuchi, Tetsuya Taguchi, et al.. (2000). A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.. International Journal of Oncology. 17(1). 119–25. 7 indexed citations
9.
Murakami, Hiroshi, M Furihata, Yuji Ohtsuki, & Shohei Ogoshi. (1999). Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 434(2). 153–158. 76 indexed citations
10.
11.
12.
Furihata, M, et al.. (1998). Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. British Journal of Cancer. 77(1). 92–97. 51 indexed citations
13.
Furihata, M, et al.. (1998). Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter. British Journal of Cancer. 77(5). 783–788. 33 indexed citations
14.
Kagawa, Shunsuke, et al.. (1998). Determination of p53 protein and high-risk human papillomavirus DNA in carcinomas of the renal pelvis and ureter.. International Journal of Molecular Medicine. 1(4). 703–7. 3 indexed citations
15.
Inoue, Keiji, et al.. (1998). Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 433(6). 511–515. 26 indexed citations
16.
Ogoshi, Shohei, et al.. (1998). High-risk human papillomavirus infection and overexpression of p53 protein in squamous cell carcinoma of the esophagus from Japan. Diseases of the Esophagus. 11(3). 162–167. 20 indexed citations
17.
Sonobe, H, Y Ohtsuki, J. Iwata, et al.. (1995). Myolipoma of the round ligament: report of a case with a review of the English literature. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 427(4). 455–8. 16 indexed citations
18.
19.
Ohtsuki, Y, Takashi Oka, M Furihata, et al.. (1989). Electron microscopic study of suppressive effects on the production of human T-lymphotropic virus type I (HTLV-I)1 with human interferons. 22(2). 205–213. 2 indexed citations
20.
Ohtsuki, Y, Ichiro Miyoshi, Takashi Oka, et al.. (1988). Immunocytochemical and ultrastructural characterization of human T-lymphotropic virus type I (HTLV-I)-producing rabbit lymphoid cell lines. Archives of Virology. 100(3-4). 245–254. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Cao Breakdown of academic impact, for papers by Barbara Loftus Breakdown of academic impact, for papers by Shi‐Xue Hu Breakdown of academic impact, for papers by Frank B. Fromowitz Breakdown of academic impact, for papers by Antonella De Stefani Breakdown of academic impact, for papers by J W Shay Breakdown of academic impact, for papers by Jeannine Lacroix Breakdown of academic impact, for papers by C. Fisher Breakdown of academic impact, for papers by Andre L. Reed Breakdown of academic impact, for papers by Concetta Chiarelli
Rankless by CCL
2026